Портал психологических изданий PsyJournals.ru
Каталог изданий 126Рубрики 53Авторы 9654Новости 1896Ключевые слова 5095 Правила публикацииВебинарыRSS RSS
Психология и право - №2 / 2011 | Перейти к описанию
Web of Science СС

Включен в Web of Science СС (ESCI)



Рейтинг Science Index РИНЦ 2019

48 место — направление «Психология»

0,217 — показатель журнала в рейтинге SCIENCE INDEX

0,852 — двухлетний импакт-фактор


Психология и право

Издатель: Московский государственный психолого-педагогический университет

ISSN (online): 2222-5196

DOI: https://doi.org/10.17759/psylaw

Лицензия: CC BY-NC 4.0

Издается с 2010 года

Периодичность: 4 номера в год

Формат: сетевое издание

Доступ к электронным архивам: открытый

«Психология и право»

мобильное приложение
для iPad и iPhone

Доступно в App Store
Скачайте бесплатно


AD/HD and criminality: Differential diagnostic and therapetic/prophylactic aspects (A general literature study and a description of Norwegian challeges in the field) 846

Хартвиг П.
кандидат психологических наук, психиатр, старший научный сотрудник Центра исследований и образования в области судебной психиатрии, Университетcкого госпиталя, Осло, Норвегия
e-mail: paal.hartvig@kompetanse-senteret.no


The impact of AD/HD (Attention Deficit/Hyperactivity Disorder) as a background factor for criminal activity is under discussion, both in the society and among professionals within psychiatry/psychology and other medical disciplines. A central topic in the discussion is whether a useful reduction of such activity can be reached by pharmacological treatment of the disorder. Studies of relevant international literature, mainly through the last 15 years have been made in the Medline/PubMed databases by combination of the terms AD/HD, and ASPD (Antisocial Personality Disorder). Additional literature has also been gathered. The main focus has been on young adult persons and upwards in age, much less on childhood and early adolescence. The literature shows that adult AD/HD and ASPD show distinctly common features, but also definite differences, both in clinical and neuro-physiological/-chemical respects. A priori, a pharmacological treatment of well diagnosed adult AD/HD, even in co-morbidity with ASPD, might be beneficial. Mostly used are the central stimulants methylphenidate and dexamphetamine, but atomoxetine, related to modern antidepressants, has also been introduced and validated. In Norway there has been an initial optimism leading to many, and at times weakly grounded, attempts to treat imprisoned or paroled persons with central stimulants. The results have been varying and often disappointing. This process and a current opinion on state of the art of such treatment will be described in the last part of the article.

Ссылка для цитирования

Фрагмент статьи


Through later years, the Norwegian and international media have had many contributions regarding the possible causal effect from AD/HD (Attention Deficit/Hyperactivity Disorder) on criminal behaviour, and there seems to be uncertainty and partly disagreement among professionals in the psychiatric field regarding to which degree this is a fact. On this background the author has performed studies of relevant recent and older scientific literature, which will be displayed and given reflections to. Only a limited part of the studied literature will be referred specifically. The main focus in the article is AD/HD among adults from young age and upwards; references to studies in child and early youth ages are less focused.

There is both a qualitative and quantitative difference in the occurrence of adult AD/HD in men and women. Trans-nationally, prevalence in men of 4.1 and 2,7 % in women has been reported [16]. Prevalence and characteristics of the disorder in the population of female prisoners (in Norway 5 % of the imprisoned) is an interesting research challenge, but the gender aspect will be treated only to a small extent in this article. Interested readers are referred to a recent German study on this aspect [37]. The core in the literature search has been associations between AD/HD and Antisocial Personality Disorder (ASPD). These terms and others following in the article are chosen from the American psychiatric diagnostic system DSM-IV [1], because this is most often used in international research connections. The official diagnostic system in Norway and many other countries, ICD-10 [49], has related, but not identical names for the corresponding diagnostic groups.


  1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders Fourth Edition (DSM-IV. Washington DC: APA, 1994.
  2. Blair R. J. R. Neurocognitive models of aggression, the antisocial personality disorders, and psychopathy, Journal of Neurology, Neurosurgery and Psychiatry 2001; 71: 727−31.
  3. Blair R. J. R. Neurobiological basis of psychopathy. Br J Psychiatry 2003; 182: 5−7.
  4. Blum K. ed. Handbook of Psychiatric Genetics. Boca Raton, Fl: CRC Press, 1996.
  5. Chen T., Blum K., Mathews D., Fisher L., Schnautz N., Braverman E.R. et al. Are dopamine genes involved in a predisposition to pathological aggression? Medical Hypotheses 2005; 65: 703−7.
  6. Comings D. E., Chen T., Blum K., Blum S. H. Neurogenic interactions and aberrant behavioural co-morbidity of attention deficit hyperactivity disorder (AD/HD): dispelling myths. Theor Biol Med Model. 2005: 2−50.
  7. Cooke D. J., Forth A. E., Hare R. D. Psychopathy: Theory, Research and Implication for Society. London: Kluwer Academic Publishers, 1998.
  8. Dabbs J. M. jr., Jurkovic I., Frady R. L. Salivary testosterone and cortisol among late adolescent male offenders. J Abnorm Child Psychol. 1991; 19: 469−78.
  9. Dadds M. R., Rhodes T. Aggression in young children with concurrent callous-unemotional traits: can the neurosciences inform progress and innovation in treatment approaches? Phil Trans R Soc B 2008; 363: 2567− 6.
  10. De Lisi M., Umphress Z. R., Vaughn M. G. The criminology of the amygdala. Crim Justice Behav. 2009; 36: 1241−52.
  11. Directorate of Social and Health Affairs. Manual for diagnosis and treatment of AD/HD- IS 1244. (In Norwegian). Oslo: Shdir, 2005.
  12. Doyle R. The history of adult attention-deficit/hyperactivity disorder. Psychiatr Clin North Am. 2004; 27: 203−14.
  13. Ellis L., Walsh A. Criminology: A global perspective. Boston MA: Allyn & Bacon, 2000.
  14. Fallgatter A. J., Ehlis A. C., Rosler M., Strik W. K., Blocher D., Herrmann M. J. Diminished prefrontal brain function in adults with psychopathology in childhood related to attention deficit hyperactivity disorder. Psychiatry Res. 2005; 138: 157−-69.
  15. Farrington D. P., Loeber R., Kammen W. B. Long term outcome of hyperactivity-impulsivity-attention deficit and conduct problems in childhood. In: Robins L. N., Rutter M. (Еds). Straight and devious pathways from childhood to adulthood (pp. 62-81). Cambridge: Cambridge university press, 1990.
  16. Fayad J., De Graf R., Kessler R., Alonso J., Angermeyer M., Demyttenaere K. et al. Cross-national prevalence and correlates of adult attention-deficit hyperactivity disorder. Br J Psychiatry 2007; 190: 402−09.
  17. Fazel S., Doll H., Långstrøm N. Mental disorders among adolescents in juvenile detention and correctional facilities: a systematic review and meta-regression analysis of 25 surveys. J Am Acad Child Adolesc Psychiatry 2008; 47(9): 1010−9.
  18. Fazel S., Danesh J. Serious mental disorder in 23 000 prisoners: a systematic review of 62 surveys. Lancet 2002; 359: 545−550.
  19. Filipek P.A., Semrud-Clikeman M., Steingard R. J., Renshaw P. F., Kennedy D. N., Biederman J. Volumetric MRI analysis comparing subjects having attention-deficit hyperactivity disorder with normal conrols. Neurology 1997; 48: 589−601.
  20. Frankle W. G., Lombardo I., New A. S., Goodman M., Talbot P. S., Huang Y. et al. Brain serotonin transporter distribution in subjects with impulsive aggressivity: a positron emission study with (11C) DASB. Biol Psychiatry 2005; 162: 915−23.
  21. Gudjonsson G., Sigurddson J., Young S., Newton A., Peersen M. Attention deficit hyperactivity disorder (ADHD) How do ADHD symptoms relate to personality among prisoners? Pers Individ Dif. 2009; 47: 64−8.
  22. Hare R. D. Manual for the Hare Psychopathy checklist-Revised. Toronto: Multi-Health Systems, 1992.
  23. Johannsson P., Kerr M., Andershed H. Linking adult psychopathy with childhood hyperactivity-impulsivity-attention problems and conduct problems through retrospective self-reports. J Pers Disord. 2005; 19: 94−101.
  24. Kessler R. C., Adler L. A., Barkley R. A., Biederman J., Conners C. K., Araone C. V. et al. Patterns and predictors of attention-deficit/hyperactivity disorder persistence into adulthood: results from the national comorbidity survey replication. Biol Psychiatry 2005; 57: 1442−51.
  25. Lynam D. Early identification of chronic offenders: Who is the fledgling psychopath? Psychol Bull. 1996; 120: 209−34.
  26. Manuzza S., Klein R. G., Bessler A., Malloy P., La Padula M. Adult psychiatric status of hyperactive boys brown up. Am J Psychiatry 1998; 155: 493−8.
  27. McArdle P. Attention–deficit hyperactivity disorder and life-span development. Br J Psychiatry 2004; 184: 468−9.
  28. McGough J. J., Barkley R. A. Diagnostic controversies in adult attention deficit hyperactivity disorder. Am J Psychiatry 2004; 161: 1948−56.
  29. Myhr K. Atomoxetin in the treatment of AD/HD (In Norwegian). Tidsskr Nor Laegeforen. 2006; 126: 457−8.
  30. National knowledge centre for the health service. Treatment with central stimulants of AD/HD in adults. (In Norwegian). Oslo: The knowledge centre, 2005.
  31. Paris J. A Biopsychosocial Model of Psychopathy. In: Millon T., Simonsen E., Birket-Smith M., Davis R. (Eds). Psychopathy, Antisocial, Criminal and Violent Behavior (pp.277−90). New York, London: The Guilford Press, 1998.
  32. Prior M., Sanson A. Attention deficit disorder with hyperactivity; a critique. J Child Psychol Psychiatry 1986; 27: 307−19.
  33. Raine A., Lenz T., Bihrle S., Lacasse L., Colletti P. Reduced grey matter volume and reduced autonomic activity in antisocial personality disorder. Arch Gen Psychiatry 2000; 57: 119−27.
  34. Rasmussen K., Almvik R., Levander S. Attention deficit hyperactivity disorder, reading disability, and personality disorders in a prison population. J Am Acad psychiatry Law 2001; 29: 186−93.
  35. Remschmidt H. Global consensus on AD/HD/HKD. Eur Child Adolesc Psychiatry 2005; 14: 127−37.
  36. Robins L.N. Deviant children grown up. Baltimore: Williams & Wilkins, 1966.
  37. Røsler M., Retz W., Yaqoobi K., Burg E., Retz-Junginger P. Attention deficit/hyperactivity disorder in female offenders: prevalence, psychiatric comorbidity and psychosocial implications. Eur Arch psychiatry Clin Neurosci. 2008; 259: 98−105.
  38. Røsler M., Retz W., Retz-Junginger P., Hengesch G., Schneider M., Supprian T. et al. Prevalence of attention deficit/hyperactivity disorder (ADHD) and comorbid disorders in young male prison inmates. Eur Arch Psychiatry Clin Neurosci. 2004; 254: 365−71.
  39. Scarpa A., Raine A. The psychophysiology of antisocial behaviour: Interactions with environmental experiences. In: Walsh A, Ellis L (Еds). Biosocial Criminology: Challenging environmentalism’s supremacy (pp. 209-26). Hauppage, NY: Nova Science, 2003.
  40. Schilling C. M., Walsh A., Yun I. ADHD and criminality: A primer on the genetic, neurobiological, evolutionary, and treatment literature for criminologists. J Crim Justice 2010, e-pub ahead of print.
  41. Spivak B., Vered Y., Yoran-Heresch R., Averbuch E., Mester R., Graf E. et al. Circulatory levels of catecholamines, serotonin and lipids in attention deficit hyperactive disorder. Acta Psychiatr Scand. 1999; 99: 300−4.
  42. Søderstrøm H., Sjødin A. K., Carlstedt A., Forsman A. Adult psychopathic personality with childhood-onset hyperactivity and conduct disorder: a central problem constellation in forensic psychiatry. Psychiatry Res 2004; 121: 271−80.
  43. Torgersen S., Cramer V., Kringlen E. Mental disorders in different town districts in Oslo (In Norwegian). Norsk Epidemiologi 2002; 12: 265−8.
  44. Torgersen T., Gjervan B., Rasmussen K. ADHD in adults: A study of clinical characteristics, impairment and comorbidity. Nord J Psychiatry 2006; 60: 38 −43.
  45. Van de Wiel N. M., Van Goozen S. H., Matthys W., Snoek H., Van Engeland H. Cortisol and treatment effect in children with disruptive behaviour disorders: a preliminary study. J Am Acad Child Adolesc Psychiatry 2004; 43: 1011−8.
  46. Vevera J., Zukov I., Morcinek T., Papezova H. Cholesterol concentrations in violent and non- violent women suicide attempters. Eur Psychiatry 2003; 18: 23−27.
  47. Walder D. J., Walker E. F., Lewine R. J. Cognitive functioning, cortisol release, and symptom severity in patients with schizophrenia. Biol Psychiatry 2000; 48: 1121−32.
  48. Waschbusch D., Pelham W. jr., Jennings J., Greiner A., Tarter R., Moss H. Reactive aggression in boys with disruptive behavior disorders: behavior, physiology, and affect. J Abnorm Child Psychol. 2002; 30: 641−56.
  49. Webster C. D., Jackson M. A. A clinical perspective on impulsivity. In: Webster C.D., Jackson M.A. (Eds). Impulsivity,Theory, Assessment, and Treatment. New York, London: The Guilford Press, 1997, 13−31.
  50. Yang Y., Raine A., Lenz T., Bihrle S., Lacasse L., Colletti P. Volume reduction in prefrontal grey matter in unsuccessful criminal psychopaths. Biol Psychiatry 2005; 57: 1103−8.
  51. Aanonsen N.O. AD/HD, Diagnosis, clinic and treatment in adults (In Norwegian). Oslo Gyldendal Akademisk, 2000.
О проекте PsyJournals.ru

© 2007–2021 Портал психологических изданий PsyJournals.ru  Все права защищены

Свидетельство регистрации СМИ Эл № ФС77-66447 от 14 июля 2016 г.


Creative Commons License Репозиторий открытого доступа     Рейтинг репозиториев Webometrics